Search research articles
Contact Us
Filters
Showing results (211-220 of 520) with videos related to
Page
of 52
Sort By:
World Journal of Nuclear Medicine
|
May 4, 2026
A Clinical Impact Study of Myocardial Perfusion Imaging Comparing Three Different Cardiac Software Packages at 1-Year Follow-Up
Amal Paul, Ashwini Kalshetty, Sandip Basu
World Journal of Nuclear Medicine
|
July 3, 2026
Observation on Discordant Treatment Response on [ <sup>18</sup> F]FDG and [ <sup>68</sup> Ga]Ga-FAPI-04 PET/CT in Radioiodine-Refractory Thyroid Carcinoma Treated with Lenvatinib
Rangat Bagasariya, Sunita Sonavane, Sandip Basu
Nuclear Medicine Communications
|
April 29, 2015
Correlation and discordance of tumour proliferation index and molecular imaging characteristics and their implications for treatment decisions and outcome pertaining to peptide receptor radionuclide therapy in patients with advanced neuroendocrine tumour: developing a personalized model
Sandip Basu, Rohit Ranade, Pradeep Thapa
Clinical Nuclear Medicine
|
August 2, 2007
Detection of unsuspected metachronous second primary malignancy giving rise to supposed "non-iodine avid metastasis" in differentiated thyroid carcinoma
Sandip Basu, Narendra Nair, Tanuja Shet
Clinical Nuclear Medicine
|
October 14, 2015
68Ga DOTATATE PET/CT of Synchronous Meningioma and Prolactinoma
Sandip Basu, Rohit Ranade, Suman Hazarika
PET Clinics
|
December 3, 2014
Assessment of treatment response using PET
Sandip Basu, Rakesh Kumar, Rohit Ranade
Hellenic Journal of Nuclear Medicine
|
April 23, 2010
Furosemide for the diagnosis of complete or partial ureteropelvic junction obstruction
Niovi Karavida, Sandip Basu, Philip Grammaticos
Hellenic Journal of Nuclear Medicine
|
August 14, 2009
(18)F-FDG-PET in restaging primary maxillary sinus melanoma with isolated gall bladder metastasis
Sandip Basu, M Houseni, Abass Alavi
World Journal of Nuclear Medicine
|
July 4, 2017
<sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Metastatic or Advanced and Inoperable Primary Neuroendocrine Tumors of Rare Sites
Pradeep Thapa, Rahul Parghane, Sandip Basu
European Journal of Nuclear Medicine and Molecular Imaging
|
October 24, 2007
Evolving concept of imaging bone marrow metastasis in the twenty-first century: critical role of FDG-PET
Sandip Basu, Drew Torigian, Abass Alavi
Page
of 52
Search research articles
Search
Showing results (211-220 of 520) with videos related to
Sort By:
Page
of 52
World Journal of Nuclear Medicine
|
May 4, 2026
A Clinical Impact Study of Myocardial Perfusion Imaging Comparing Three Different Cardiac Software Packages at 1-Year Follow-Up
Amal Paul, Ashwini Kalshetty, Sandip Basu
World Journal of Nuclear Medicine
|
July 3, 2026
Observation on Discordant Treatment Response on [ <sup>18</sup> F]FDG and [ <sup>68</sup> Ga]Ga-FAPI-04 PET/CT in Radioiodine-Refractory Thyroid Carcinoma Treated with Lenvatinib
Rangat Bagasariya, Sunita Sonavane, Sandip Basu
Nuclear Medicine Communications
|
April 29, 2015
Correlation and discordance of tumour proliferation index and molecular imaging characteristics and their implications for treatment decisions and outcome pertaining to peptide receptor radionuclide therapy in patients with advanced neuroendocrine tumour: developing a personalized model
Sandip Basu, Rohit Ranade, Pradeep Thapa
Clinical Nuclear Medicine
|
August 2, 2007
Detection of unsuspected metachronous second primary malignancy giving rise to supposed "non-iodine avid metastasis" in differentiated thyroid carcinoma
Sandip Basu, Narendra Nair, Tanuja Shet
Clinical Nuclear Medicine
|
October 14, 2015
68Ga DOTATATE PET/CT of Synchronous Meningioma and Prolactinoma
Sandip Basu, Rohit Ranade, Suman Hazarika
PET Clinics
|
December 3, 2014
Assessment of treatment response using PET
Sandip Basu, Rakesh Kumar, Rohit Ranade
Hellenic Journal of Nuclear Medicine
|
April 23, 2010
Furosemide for the diagnosis of complete or partial ureteropelvic junction obstruction
Niovi Karavida, Sandip Basu, Philip Grammaticos
Hellenic Journal of Nuclear Medicine
|
August 14, 2009
(18)F-FDG-PET in restaging primary maxillary sinus melanoma with isolated gall bladder metastasis
Sandip Basu, M Houseni, Abass Alavi
World Journal of Nuclear Medicine
|
July 4, 2017
<sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Metastatic or Advanced and Inoperable Primary Neuroendocrine Tumors of Rare Sites
Pradeep Thapa, Rahul Parghane, Sandip Basu
European Journal of Nuclear Medicine and Molecular Imaging
|
October 24, 2007
Evolving concept of imaging bone marrow metastasis in the twenty-first century: critical role of FDG-PET
Sandip Basu, Drew Torigian, Abass Alavi
Page
of 52